title: Fulvestrant and male breast cancer: a case series.
authors.forename: F
authors.initials: F
authors.lastname: Zagouri
authors.forename: T N
authors.initials: TN
authors.lastname: Sergentanis
authors.forename: D
authors.initials: D
authors.lastname: Chrysikos
authors.forename: E
authors.initials: E
authors.lastname: Zografos
authors.forename: M
authors.initials: M
authors.lastname: Rudas
authors.forename: G
authors.initials: G
authors.lastname: Steger
authors.forename: G
authors.initials: G
authors.lastname: Zografos
authors.forename: R
authors.initials: R
authors.lastname: Bartsch
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D018567:Breast Neoplasms, Male / Q000188:drug therapy*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D000077267:Fulvestrant; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D000077267:Fulvestrant; D004958:Estradiol